Skip to content

Depression: all studies

Page 757 of 1,034: studies 7,561 to 7,570 of 10,336, newest first. Back to the depression overview

Research

Amigas Latinas Motivando el Alma: In-Person and Online Delivery of an Intervention to Promote Mental Health Among Latina Immigrant Women.

Journal of Integrative and Complementary Medicine June 20, 2022 India J. Ornelas, Georgina Perez, Serena Maurer et al.

Objective: A few mindfulness-based interventions have been developed for Latina immigrant populations. We describe the feasibility and acceptability of Amigas Latinas Motivando el Alma (ALMA), a culturally grounded intervention developed to prevent and reduce depression and anxiety among Latina immigrants. We also compare participation in the intervention in-person with an online adaptation...

β-carboline-independent antidepressant-like effect of the standardized extract of the barks of Mimosa tenuiflora (Willd) Poir. occurs via 5-HT2A/2C receptors in mice

Journal of Psychopharmacology June 20, 2022 Luiz Antonio Miranda de Souza Duarte Filho, Isabela Araújo E Amariz, Rodolfo Hideki Vicente Nishimura et al. 12 citations

Background: Depression is a psychiatric disorder with limited therapy options. Psychedelics are new antidepressant candidates, being the ayahuasca one of the most promising ones. A synergistic combination of N,N-dimethyltryptamine (DMT) and β-carbolines allows ayahuasca antidepressant properties. Another psychedelic and DMT-containing beverage is the jurema wine used religiously by indigenous...

DOI: 10.1177/02698811221104050 (opens in new tab) Antidepressant Traditional medicine Pharmacology Receptor

Einstellungen von Expertinnen und Experten für psychische Gesundheit gegenüber Psilocybin

Fortschritte der Neurologie · Psychiatrie June 20, 2022 Christopher W. Schmidt, Max Wolff, Gerhard Gründer et al. 5 citations

Zusammenfassung Ziel der Studie In den letzten Jahren konnten Studien, in denen die Verwendung von Psilocybin zur Behandlung psychischer Störungen untersucht wurde, vielversprechende Ergebnisse zeigen. Vor diesem Hintergrund wurden Einstellungen von ausgebildeten Psychiater*innen und Psychotherapeut*innen zu Psilocybin und Psilocybin-unterstützten Therapien untersucht. Methodik Eine...

Applying Lessons From Cannabis to the Psychedelic Highway

JAMA Health Forum June 17, 2022 Kevin F. Boehnke, Alan K. Davis, Jenna McAfee 20 citations

In 2020, Oregon became the first state in the US to decriminalize use of many illicit substances, including mushrooms containing psilocybin, and allow adults aged 21 years and older to take psilocybin under supervision in state-licensed service centers.Numerous states and municipalities have since proposed similar policies, 1 a process catalyzed by excitement about positive clinical trials of...

Preface to the special issue “Psychedelics and Neurochemistry”

Journal of Neurochemistry June 14, 2022 C. Nichols, D. Nichols

Psychedelics are a relatively recent field of research that had not gained much support half a century ago, yet it developed into a much acknowledged, highly relevant field that extends to many people's lives. Psychedelics have demonstrated profound and durable therapeutic potential for the treatment of several psychiatric disorders including depression, anxiety, and substance use disorders,...

Effects of a Neuroscience-Based Mindfulness Meditation Program on Psychological Health: Pilot Randomized Controlled Trial

JMIR Formative Research June 9, 2022 Sarah Lynn, Julia C. Basso

Background Mindfulness and meditation have a rich historical tradition, and a growing scientific base of evidence supports their use in creating positive psychological and neuroplastic changes for practitioners. Although meditation can be taught in various ways, the scientific community has yet to systematically study the impact of different types of meditation on neuropsychological outcomes,...

Konseling dan Mindfulness Based Cognitive Theraphy (MBCT): Treatment bagi Pasien Kanker

Assertive: Islamic Counseling Journal June 3, 2022 Adhitya Ridwan Budhi Prasetyo Nugroho, Umi Halwati

Masalah psikologis pada pasien kanker seperti depresi dapat menyebabkan beban tambahan selama perawatann. berbagai faktor yang memainkan peran kunci dalam depresi selain faktor biologis, Faktor individu dan faktor interpersonal dan sosial, dan kurangnya dukungan sosial juga berdampak pada kondisi mental pasien tersebut. Teknik MBCT sebagai terapi kognitif berbasis mindfulness telah ditemukan...

Neuropsychological effect on long-term Ayahuasca use

Counseling And Psychological Services Dissertations (Georgia State University) June 2, 2022 Tiffany D Tucker 1 citation

Ayahuasca is a hallucinogenic tea used in religious ritual ceremonies in eastern parts of South America. Ayahuasca is becoming more popular in western countries for therapeutic use for depression, drug addiction, and emotional distress (Domínguez-Clavé et al., 2016). Previous research has explored the effects ayahuasca may have on cognition, neurological functioning, and psychopathology....

DOI: 10.57709/12628841 (opens in new tab) Ayahuasca Term time Neuropsychology Cognition

Systematic Review of Mind-Body Modalities to Manage the Mental Health of Healthcare Workers during the COVID-19 Era.

Healthcare June 1, 2022 Chan-Young Kwon, Boram Lee

Healthcare workers (HCWs) have suffered physical and psychological threats since the beginning of the coronavirus disease 2019 (COVID-19) pandemic. Mind-body modalities (MBMs) can reduce the long-term adverse health effects associated with COVID-specific chronic stress. This systematic review aims to investigate the role of MBMs in managing the mental health of HCWs during the COVID-19...

DOI: 10.3390/healthcare10061027 (opens in new tab) Full text (opens in new tab) Mental health Pandemics Mind-body therapies Healthcare personnel +1

The cognitive effects of esketamine: what do we know so far?

European Psychiatry June 1, 2022 M. Barbosa, R. Guedes

IntroductionEsketamine is an S-enantiomer of ketamine approved by the EMA for treatment-resistant depression (TRD). As an NMDA receptor antagonist, its administration results in increase of glutamate release and AMPA receptor activation, supporting both rapid-onset and long-term antidepressant effects. Short-term tolerability seems acceptable but major concerns remain regarding long-term...